NCT01831089 2020-04-10Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid TumorsPharmaMarPhase 1 Completed69 enrolled 17 charts